Unknown

Dataset Information

0

Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges.

ABSTRACT: The incidence and case-fatality rates (CFRs) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, the etiological agent for Coronavirus Disease 2019 (COVID-19), have been rising unabated. Even though the entire world has been implementing infection prevention and control measures, the pandemic continues to spread. It has been widely accepted that preventive vaccination strategies are the public health measures for countering this pandemic. This study critically reviews the latest scientific advancement in genomics, replication pattern, pathogenesis, and immunopathology of SARS-CoV-2 infection and how these concepts could be used in the development of vaccines. We also offer a detailed discussion on the anticipated potency, efficacy, safety, and pharmaco-economic issues that are and will be associated with candidate COVID-19 vaccines.

SUBMITTER: Abdullahi IN 

PROVIDER: S-EPMC7993231 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The incidence and case-fatality rates (CFRs) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, the etiological agent for Coronavirus Disease 2019 (COVID-19), have been rising unabated. Even though the entire world has been implementing infection prevention and control measures, the pandemic continues to spread. It has been widely accepted that preventive vaccination strategies are the public health measures for countering this pandemic. This study critically reviews the  ...[more]

Similar Datasets

Unknown Oral and intranasal vaccines against SARS-CoV-2: Current progress, prospects, advantages, and challenges.
| S-EPMC8959423 | biostudies-literature
Unknown The COVID-19 Vaccines: Recent Development, Challenges and Prospects.
| S-EPMC8067284 | biostudies-literature
Unknown COVID-19 vaccines: rapid development, implications, challenges and future prospects.
| S-EPMC7937046 | biostudies-literature
Unknown Prospects and Challenges in the Development of Universal Influenza Vaccines.
| S-EPMC7563311 | biostudies-literature
Unknown Development of SARS-CoV-2 vaccines: challenges, risks, and the way forward.
| S-EPMC7754925 | biostudies-literature
Unknown Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa.
| S-EPMC7481764 | biostudies-literature
Unknown Mumps Vaccines: Current Challenges and Future Prospects.
| S-EPMC7468195 | biostudies-literature
Unknown Therapeutic cancer vaccines: advancements, challenges, and prospects.
| S-EPMC10716479 | biostudies-literature
Unknown Potential SARS-CoV-2 vaccines: Concept, progress, and challenges.
| S-EPMC8006194 | biostudies-literature
Unknown The success of SARS-CoV-2 vaccines and challenges ahead.
| S-EPMC8279572 | biostudies-literature